zgc:92818 Antibody

What is zgc:92818 protein and what applications has the antibody been validated for?

The zgc:92818 protein (Uniprot No. Q6DGQ4) is a protein expressed in Danio rerio (zebrafish). The commercially available antibody against this protein has been validated for specific laboratory applications including Enzyme-Linked Immunosorbent Assay (ELISA) and Western Blot (WB) . These validation tests ensure proper identification of the target antigen. When planning experiments, researchers should prioritize applications explicitly mentioned in the product documentation to ensure reliability of results.

What are the optimal storage and handling conditions for zgc:92818 Antibody?

The zgc:92818 Antibody requires storage at either -20°C or -80°C upon receipt . Researchers should avoid repeated freeze-thaw cycles, as this can diminish antibody activity and binding efficiency. For preservation of antibody function, the antibody is typically supplied in a storage buffer containing:

• 0.03% Proclin 300 (preservative)

• 50% Glycerol

• 0.01M PBS, pH 7.4

These components help maintain antibody stability during storage. Aliquoting the antibody upon receipt into single-use volumes is recommended to prevent degradation from multiple freeze-thaw cycles.

What controls should be included when using zgc:92818 Antibody in experiments?

For rigorous experimental design, include the following controls when working with zgc:92818 Antibody:

• Positive control: Zebrafish tissue or cell lysate known to express the target protein

• Negative control: Non-zebrafish samples or zebrafish samples where the protein is not expressed

• Secondary antibody-only control: Omit primary antibody to detect non-specific binding

• Isotype control: Use rabbit IgG (matching the polyclonal nature of zgc:92818 Antibody) to identify non-specific binding

These controls are critical for proper interpretation of results. As stated in published guidelines: "Every experiment should include a positive and negative control to assess antibody performance, ideally a set of samples with variable expression levels of the protein of interest" .

How can I validate the specificity of zgc:92818 Antibody for my experiments?

Validating antibody specificity requires a multi-faceted approach:

• Genetic validation: Compare antibody signals in wild-type vs. knockout/knockdown models of zgc:92818

  • "The specificity of an antibody can be assessed by comparing its performance in cell lines with and without the target protein; signal in knock-out cell lines can be attributed to unspecific binding"

• Peptide competition assay: Pre-incubate antibody with excess recombinant zgc:92818 protein before application

  • If the antibody is specific, this should abolish or significantly reduce signal

• Western blot validation: Confirm that the antibody detects a single band of appropriate molecular weight

  • "When assessing specificity, sensitivity, and reproducibility it is key to keep your intended application in mind"

• Cross-reactivity testing: Test the antibody against closely related proteins to ensure selectivity

Document all validation steps with appropriate controls for publication and reproducibility purposes.

What are best practices for optimizing zgc:92818 Antibody concentration in Western blotting?

Optimizing antibody concentration involves systematic titration:

• Initial dilution range: Begin with 1:250, 1:500, and 1:1000 dilutions based on antibody validation studies

• Signal-to-noise assessment: "If antibody-based protein evaluation is performed in a quantitative manner, signal-to-noise ratio and dynamic range are two of the most critical objective parameters to define the best antibody concentration for a given assay"

• Optimization protocol:

  • Test multiple dilutions on identical samples

  • Compare signal intensity and background levels

  • Select concentration that provides optimal signal-to-noise ratio

  • Document optimal conditions for reproducibility

• Blocking optimization: Test different blocking agents (5% milk, 5% BSA) to minimize background while maintaining specific signal

Creating a small optimization matrix with different antibody concentrations and blocking conditions can efficiently identify optimal parameters.

How should I approach immunoprecipitation experiments using zgc:92818 Antibody?

For successful immunoprecipitation with zgc:92818 Antibody, follow these methodological steps:

• Antibody preparation: Secure antibody to a solid support such as Protein A/G beads

  • "Efforts to immunoprecipitate rRBD with Protein-A/G bound CU-28-24 were successful in that after multiple washings of the bound column, rRBD was eluted from the column"

• Sample preparation:

  • Prepare fresh zebrafish tissue/cell lysates in an IP-compatible buffer

  • Pre-clear lysate with beads alone to reduce non-specific binding

  • Use approximately 2-5 μg of antibody per 500 μg of protein lysate

• Incubation protocol:

  • Incubate antibody-bound beads with pre-cleared lysate overnight at 4°C with gentle rotation

  • Perform multiple wash steps (3-5 washes) with IP buffer

  • Elute bound proteins using low pH buffer or SDS sample buffer

• Validation:

  • Confirm successful IP by immunoblotting with the same or different zgc:92818 antibody

  • Include IgG control to identify non-specific protein binding

Document all steps carefully for reproducibility and troubleshooting.

What techniques are recommended for determining the affinity of zgc:92818 Antibody for its target?

Determining antibody affinity requires specialized techniques:

• Surface Plasmon Resonance (SPR):

  • Immobilize the zgc:92818 protein on a sensor chip

  • Measure association and dissociation rates of the antibody

  • Calculate the equilibrium dissociation constant (Kd)

  • "Biolayer interferometry experiments were performed by measuring the association and dissociation kinetics of immobilized antibody binding to a soluble protein"

• Competitive ELISA:

  • Measure the antibody's ability to compete with a reference molecule

  • Calculate IC50 values from dose-response curves

  • "The competition experiment showed that 54042-4 competed for binding to SARS-CoV-2 S protein with COV2-2130 but not COV2-2196 or CR3022"

• Isothermal Titration Calorimetry (ITC):

  • Direct measurement of binding thermodynamics

  • Provides both affinity and stoichiometry data

These techniques require specialized equipment but provide valuable quantitative data about antibody-antigen interactions.

How can I troubleshoot non-specific binding when using zgc:92818 Antibody in immunohistochemistry?

When encountering non-specific binding, implement this systematic troubleshooting approach:

"Pay attention to protein-specific antigen retrieval methods, as it is best to follow the vendor's recommendations when optimizing antibody concentration. If the assay does not perform as expected, different retrieval methods may yield better results" .

What strategies exist for multiplex detection involving zgc:92818 Antibody?

For multiplex detection incorporating zgc:92818 Antibody:

• Antibody selection considerations:

  • Choose antibodies raised in different host species to avoid cross-reactivity

  • Ensure spectral separation of fluorophores if using fluorescent detection

  • Verify that detection conditions for one antibody don't interfere with others

• Sequential detection protocol:

  • Apply zgc:92818 Antibody first and complete its detection

  • Block remaining rabbit IgG binding sites

  • Apply second primary antibody and detect with distinct methodology

  • "For multiplex detection...using antibodies from different host species simplifies detection"

• Validation requirements:

  • Test each antibody individually first

  • Compare multiplex signals to single-antibody controls

  • Document any signal reduction or interference

• Data analysis: Implement appropriate controls to adjust for any spectral overlap or signal bleed-through

Careful experimental design and validation are essential for accurate multiplex detection.

How can I assess batch-to-batch variability of zgc:92818 Antibody for long-term studies?

For longitudinal studies requiring consistent reagents, implement this batch validation workflow:

• Reference standard creation:

  • Prepare and freeze aliquots of positive control samples

  • Document baseline performance metrics with initial antibody lot

• Comparative validation protocol:

  • Test new antibody batch alongside reference sample

  • Quantify signal intensity, background levels, and specificity

  • "When referencing sources during planning and thinking, you should still refer to them by index with brackets"

• Acceptance criteria:

  • Define acceptable variation limits before starting (e.g., ±20% signal intensity)

  • Document lot numbers and validation results for each experiment

  • "All antibody-generated data should include positive and negative controls"

• Mitigation strategies:

  • Purchase sufficient antibody from single lot for entire study when possible

  • Consider developing an internal reference standard for antibody validation

This approach ensures consistent experimental conditions throughout longitudinal studies.